Literature DB >> 11461680

Human retrovirus type 5 sequences in non-Hodgkin's lymphoma of T cell origin.

S Kozireva1, S Lejniece, J Blomberg, M Murovska.   

Abstract

DNA of a recently described fifth exogenous retrovirus (HRV-5) has been found in blood samples from patients with autoimmune diseases and lymphoma. We analyzed HRV-5 sequence in DNA extracted from whole blood of 17 patients with T cell non-Hodgkin's lymphoma (NHL) and 186 patients with hematological malignancies other than NHL, using a sensitive PCR technique. While all samples of patients with hematological malignancies other than NHL were negative, 2 of the 17 patients with T cell NHL were HRV-5 DNA positive. Both HRV-5-positive patients had T cell NHL of high-grade malignancy (stage IV) and diffuse distribution of the lymphoma, including infiltration of bone marrow or lung and pleura. The difference in HRV-5 DNA detection frequency between NHL and control groups is significant (p value of 0.0004 judged by the Fisher exact test). These data, together with our previous finding of HRV-5 DNA in three B cell NHL cases, are compatible with an association between HRV-5 and NHL, of both T cell and B cell origin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461680     DOI: 10.1089/088922201750290069

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Uptake of amplifiable fragments of retrotransposon DNA from the human alimentary tract.

Authors:  A Forsman; D Ushameckis; A Bindra; Z Yun; J Blomberg
Journal:  Mol Genet Genomics       Date:  2003-10-11       Impact factor: 3.291

2.  Novel endogenous retrovirus in rabbits previously reported as human retrovirus 5.

Authors:  David J Griffiths; Cécile Voisset; Patrick J W Venables; Robin A Weiss
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 3.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.